Education
About Us
Working with TipRanks
Follow Us
Kevin Krenitsky Insider Profile
4 Followers
Kevin Krenitsky, President at CapForce, holds 8.33K shares in CapForce (Ticker: CFOR), holds 140.61K shares in Foundation Medicine (Ticker: FMI), holds 17.60K shares in Enzo Biochem (Ticker: ENZB).
Kevin Krenitsky has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kevin Krenitsky's holdings
Insider Roles
President
Roles that Kevin Krenitsky holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kevin Krenitsky
Kevin Krenitsky's Trading History
CapForce
May 23, 2016
President
Uninformative Buy
―
$199.27K
Foundation Medicine
Oct 03, 2014
―
Uninformative Buy
―
$19.26M
Enzo Biochem
Feb 02, 2010
―
Uninformative Buy
―
$12.28K
List of latest transactions for each holding click on a transaction to see Kevin Krenitsky's performance on stock
You May Also Like
Kevin Krenitsky insider profile FAQ
What is the percentage of profitable transactions made by Kevin Krenitsky?
The percentage of profitable transactions made by Kevin Krenitsky is ―.
What is the average return per transaction made by Kevin Krenitsky?
The average return per transaction made by Kevin Krenitsky is ―.
What stocks does Kevin Krenitsky hold?
Kevin Krenitsky holds: CFOR, FMI, ENZB stocks.
What was Kevin Krenitsky’s latest transaction?
Kevin Krenitsky latest transaction was an Uninformative Buy of ―.
What was Kevin Krenitsky's most profitable transaction?
Kevin Krenitsky’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kevin Krenitsky's role in CapForce?
Kevin Krenitsky's role in CapForce is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.